ClinicalTrials.Veeva

Menu
D

Discovery Clinical Trials | Stone Oak, San Antonio, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-0616
MT-2990
Lorundrostat

Parent organization

This site is a part of Discovery Clinical Trials

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials

Enlicitide Decanoate (MK-0616) (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of enlicitide decanoate, an oral proprotein convertase subtilisin/...

Enrolling
Arteriosclerosis
Hypercholesterolaemia
Drug: Enlicitide decanoate
Drug: Placebo
Locations recently updated

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Enrolling
Hypertension
Drug: lorundrostat
Drug: Placebo

Trial sponsors

Merck Sharp & Dohme (MSD) logo
M
Mitsubishi Tanabe Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems